Terms: = Germ cell tumor AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Prognosis
82 results:
1. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract] [Full Text] [Related]
2. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract] [Full Text] [Related]
3. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam KP; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
J Exp Clin Cancer Res; 2024 Jan; 43(1):13. PubMed ID: 38191418
[TBL] [Abstract] [Full Text] [Related]
4. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract] [Full Text] [Related]
5. Combined Inhibition of EZH2 and FGFR is Synergistic in bap1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
6. Functional assay for assessment of pathogenicity of bap1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer analysis of the prognostic significance of
Dong H; Zhou S; Chen X; Deng X; Fang A
Expert Rev Clin Immunol; 2024 Feb; 20(2):225-236. PubMed ID: 37882761
[TBL] [Abstract] [Full Text] [Related]
8. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
10. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
[TBL] [Abstract] [Full Text] [Related]
11. bap1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C; Wu S
Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
[TBL] [Abstract] [Full Text] [Related]
12. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.
Gelmi MC; Verdijk RM; Houtzagers LE; van der Velden PA; Kroes WGM; Luyten GPM; Vu THK; Jager MJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240204
[TBL] [Abstract] [Full Text] [Related]
13. Corneal Perforation as a Rare and Late Manifestation of Choroidal Melanoma.
Berger T; Flockerzi F; Löw U; Flockerzi E; Aljundi W; Abdin A; Daas L; Seitz B
Klin Monbl Augenheilkd; 2023 Jul; 240(7):871-877. PubMed ID: 37224861
[TBL] [Abstract] [Full Text] [Related]
14. Family Matters: germline Testing in Thoracic Cancers.
Hathaway F; Martins R; Sorscher S; Bzura A; Dudbridge F; Fennell DA
Am Soc Clin Oncol Educ Book; 2023 May; 43():e389956. PubMed ID: 37167572
[TBL] [Abstract] [Full Text] [Related]
15. A Novel Glycolysis-Related Signature for Predicting the prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract] [Full Text] [Related]
16. DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with bap1 aberrancy and prognosis in uveal melanoma.
Hoffmann F; Fröhlich A; Sirokay J; de Vos L; Zarbl R; Dietrich J; Strieth S; Landsberg J; Dietrich D
Melanoma Res; 2023 Apr; 33(2):116-125. PubMed ID: 36735464
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (bap1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
19. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With bap1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
[TBL] [Abstract] [Full Text] [Related]
20. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
Gelmi MC; Houtzagers LE; Strub T; Krossa I; Jager MJ
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682684
[TBL] [Abstract] [Full Text] [Related]
[Next]
